10-Q/A: AGBA Group Restates Q3 2023 Financials Due to Tax Error, Reports Increased Operating Losses
Quarterly Report Amendment
AGBA Group Holding Limited has restated its unaudited condensed consolidated financial statements for the quarter ended September 30, 2023, due to an error in the application of tax law related to the 2021 sale of Nutmeg, and reports increased operating losses.
Summary
- AGBA Group Holding Limited is filing an amendment to its Q3 2023 report to restate its financial statements due to an error in the application of US and Hong Kong tax law.
- The error relates to the sale of Nutmeg in 2021, where the company incorrectly recorded a $23 million income tax liability.
- The restatement results in a $23 million reduction in the income tax provision and a corresponding decrease in the accumulated deficit, with no impact on the statements of operations or cash flows.
- The company reported a net loss of $35.6 million for the nine months ended September 30, 2023, and a net loss of $12.9 million for the three months ended September 30, 2023.
- Operating expenses increased significantly, contributing to the increased losses.
- Total revenue for the nine months ended September 30, 2023, was $41.7 million, compared to $19.4 million for the same period in 2022.
- The company's cash and cash equivalents stood at $1.6 million as of September 30, 2023, with restricted cash of $20.6 million.
- The company has identified a going concern issue and is exploring funding alternatives, including a potential $50 million equity purchase agreement and a $6.2 million private placement.
Sentiment
Score: 3
Explanation: The document reveals significant financial challenges, including a restatement, increased losses, and a going concern issue. While revenue growth is positive, the overall sentiment is negative due to the company's financial instability and reliance on potential capital raises.
Positives
- Total revenue for the nine months ended September 30, 2023, more than doubled compared to the same period in 2022, reaching $41.7 million.
- The company is actively pursuing funding alternatives to address its liquidity concerns, including a potential $50 million equity purchase agreement and a $6.2 million private placement.
- The company has a share repurchase program in place, which could potentially return value to shareholders.
Negatives
- The company's net loss for the nine months ended September 30, 2023, was $35.6 million, a significant increase compared to the $13.7 million loss in the same period of 2022.
- Operating expenses have increased substantially, reaching $77.2 million for the nine months ended September 30, 2023, compared to $25.8 million in 2022.
- The company has a working capital deficit of $39.8 million as of September 30, 2023.
- The company has identified a going concern issue, indicating substantial doubt about its ability to continue as a going concern for at least one year following the date of the financial statements.
Risks
- The company's ability to continue as a going concern is dependent on its ability to successfully implement its operating plan and secure additional funding.
- The company's cash and cash equivalents are insufficient to meet its planned obligations for the next 12 months.
- The company is subject to various legal proceedings, the outcomes of which are uncertain.
- The company's operations are concentrated in Hong Kong, exposing it to economic and political risks in the region.
- The company is exposed to exchange rate risk due to its investments in foreign currencies.
- The company is subject to Nasdaq compliance requirements and may face delisting if it fails to regain compliance with the minimum bid price rule.
Future Outlook
The company expects to continue its business growth while closely monitoring future spending and is exploring various funding alternatives to finance its operations and growth strategy. The company anticipates sales volumes to return to pre-pandemic levels, especially with the re-opening of the Mainland border and the ongoing integration of Hong Kong into the Greater Bay Area.
Management Comments
- Management believes that it will be able to continue to grow its revenue base and control expenditures.
- Management is continually monitoring its capital structure and operating plans and evaluating various potential funding alternatives.
- Management believes that the company would be able to strengthen its financial position, improve its liquidity, and enhance its ability to navigate the challenging market conditions with the funding initiatives.
Industry Context
The company operates in the financial services, insurance, and healthcare sectors, which are all experiencing significant changes due to technological advancements and evolving consumer preferences. The company's focus on digital platforms and its presence in the Greater Bay Area position it to capitalize on these trends, but it also faces competition from established players and new entrants.
Comparison to Industry Standards
- AGBA's revenue growth of over 100% year-over-year is significantly higher than the average growth rate for the financial services industry, which is typically in the single-digit range.
- However, AGBA's operating losses are also much higher than industry averages, indicating a need for improved cost management.
- Compared to other fintech companies, AGBA's investment portfolio is relatively diverse, including holdings in digital banking, payments, and healthcare.
- AGBA's reliance on related party transactions is higher than industry standards, which could raise concerns about potential conflicts of interest.
- The company's going concern issue is a significant deviation from industry norms, highlighting the need for immediate and substantial improvements in its financial position.
Legal Proceedings
- The company is involved in several legal proceedings, including HCA702/2018, HCA765/2019, and HCA2097 and 2098/2020.
- The outcomes of these legal proceedings are uncertain, and the company is unable to determine the probability of the outcomes or the range of reasonably possible losses.
Related Party Transactions
- The company has significant related party transactions, including borrowings from its major shareholder and office rental and operating fees paid to the holding company.
- The company also has accounts receivable from related parties for management services rendered.
Stakeholder Impact
- Shareholders face the risk of further dilution due to potential equity raises and the risk of delisting from Nasdaq.
- Employees may be affected by potential cost-cutting measures or restructuring.
- Customers may be impacted by changes in the company's service offerings or financial stability.
- Suppliers and creditors face the risk of non-payment or delayed payments due to the company's liquidity issues.
Next Steps
- The company needs to regain compliance with Nasdaq's minimum bid price requirement by March 18, 2024.
- The company is seeking to close the sale and purchase agreement with Sony Life Singapore Pte. Ltd. by December 31, 2023.
- The company needs to secure additional funding through the equity purchase agreement and private placement.
- The company needs to continue to monitor its capital structure and operating plans and search for potential funding alternatives.
Key Dates
| Date | Description |
|---|---|
| June 2021 | AGBA received an offer from JP Morgan Chase to purchase Nutmeg. |
| September 2021 | AGBA received cash consideration for the sale of Nutmeg. |
| December 31, 2021 | AGBA recorded an income tax payable of $23 million related to the Nutmeg sale. |
| November 9, 2022 | Date of the Meteora Backstop Agreement. |
| February 24, 2023 | AGBA entered into a subscription agreement and a convertible loan note instrument with Investment A and registered 11,675,397 ordinary shares to be issued under the Share Award Scheme. |
| June 28, 2023 | AGBA entered into a provisional purchase and sale agreement to sell an office premise. |
| June 29, 2023 | AGBA and Meteora entered into an agreement to early terminate the Meteora Backstop Agreement. |
| September 7, 2023 | AGBA entered into an equity purchase agreement with Williamsburg Venture Holdings, LLC. |
| September 20, 2023 | AGBA received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. |
| September 26, 2023 | AGBA and Sony Life Singapore Pte. Ltd. extended the closing date of the transaction to December 31, 2023. |
| October 17, 2023 | AGBA completed the sale of the office premises. |
| November 7, 2023 | AGBA signed private placement binding term sheets with investors. |
| March 18, 2024 | Deadline for AGBA to regain compliance with Nasdaq's minimum bid price requirement. |
| March 26, 2024 | There were 74,391,357 ordinary shares issued and outstanding. |
| November 25, 2024 | Trial date for the HCA702/2018 legal case. |
Keywords
financial restatement, tax error, operating loss, going concern, equity purchase agreement, private placement, financial services, insurance brokerage, asset management, Hong Kong, Nasdaq compliance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.